Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China flag China · Delayed Price · Currency is CNY
7.79
-0.01 (-0.13%)
Apr 8, 2026, 3:04 PM CST

SHE:002550 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
9,7367,7497,5258,0126,1815,439
Market Cap Growth
37.15%2.97%-6.07%29.61%13.64%-7.21%
Enterprise Value
8,6957,0717,0547,5085,5824,818
Last Close Price
7.796.095.665.904.453.80
PE Ratio
23.0121.7641.3824.7734.14-
Forward PE
21.6420.0020.0020.0020.0020.00
PS Ratio
6.355.084.153.483.303.26
PB Ratio
3.533.083.043.292.922.63
P/TBV Ratio
3.703.233.233.433.082.78
P/FCF Ratio
43.5918.2717.38-468.8021.35
P/OCF Ratio
27.4015.0614.11-59.6917.14
EV/Sales Ratio
5.674.633.893.262.982.89
EV/EBITDA Ratio
20.2820.3930.4926.1325.1717.19
EV/EBIT Ratio
23.6525.0643.5033.7436.6322.94
EV/FCF Ratio
38.9316.6816.29-423.3618.91
Debt / Equity Ratio
-0.010.020.040.040.02
Debt / EBITDA Ratio
-0.060.240.360.420.15
Debt / FCF Ratio
-0.050.13-7.100.16
Net Debt / Equity Ratio
-0.38-0.35-0.27-0.15-0.28-0.34
Net Debt / EBITDA Ratio
-2.45-2.55-2.84-1.30-2.67-2.53
Net Debt / FCF Ratio
-4.70-2.09-1.522.62-44.93-2.78
Asset Turnover
0.530.550.650.870.760.62
Inventory Turnover
1.691.351.843.032.923.13
Quick Ratio
8.265.394.894.003.834.18
Current Ratio
11.847.587.906.075.305.35
Return on Equity (ROE)
15.36%13.35%7.28%14.06%8.91%-6.71%
Return on Assets (ROA)
7.95%6.30%3.64%5.24%3.84%4.87%
Return on Invested Capital (ROIC)
18.31%13.77%7.34%11.02%9.41%13.26%
Return on Capital Employed (ROCE)
12.90%10.80%6.30%8.80%6.90%9.70%
Earnings Yield
4.41%4.59%2.42%4.04%2.93%-2.43%
FCF Yield
2.29%5.47%5.75%-1.78%0.21%4.68%
Dividend Yield
1.54%1.97%2.12%2.04%2.70%3.16%
Payout Ratio
35.05%42.56%87.31%47.98%83.67%-
Buyback Yield / Dilution
0.89%2.11%-0.41%-7.16%-0.58%4.01%
Total Shareholder Return
2.41%4.08%1.71%-5.13%2.11%7.16%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.